Your browser doesn't support javascript.
loading
A Phase II/III, Multicenter, Observer-blinded, Randomized, Non-inferiority and Safety, study of typhoid conjugate vaccine (EuTCV) compared to Typbar-TCV® in healthy 6 Months-45 years aged participants.
Ok Baik, Yeong; Lee, Youngjin; Lee, Chankyu; Kyung Kim, Soo; Park, Jooyoung; Sun, Meixiang; Jung, DaYe; Young Jang, Jin; Jun Yong, Tae; Woo Park, Jeong; Jeong, Sungho; Lim, Suwon; Hyun Han, Seung; Keun Choi, Seuk.
Afiliação
  • Ok Baik Y; EuBiologics Co., Ltd., Seoul, Republic of Korea.
  • Lee Y; EuBiologics Co., Ltd., Seoul, Republic of Korea.
  • Lee C; R&D Center, EuBiologics Co., Ltd., Chuncheon, Republic of Korea.
  • Kyung Kim S; R&D Center, EuBiologics Co., Ltd., Chuncheon, Republic of Korea.
  • Park J; EuBiologics Co., Ltd., Seoul, Republic of Korea.
  • Sun M; R&D Center, EuBiologics Co., Ltd., Chuncheon, Republic of Korea.
  • Jung D; EuBiologics Co., Ltd., Seoul, Republic of Korea.
  • Young Jang J; R&D Center, EuBiologics Co., Ltd., Chuncheon, Republic of Korea.
  • Jun Yong T; R&D Center, EuBiologics Co., Ltd., Chuncheon, Republic of Korea.
  • Woo Park J; Department of Oral Microbiology and Immunology, and Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea.
  • Jeong S; Department of Oral Microbiology and Immunology, and Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea.
  • Lim S; Department of Oral Microbiology and Immunology, and Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea.
  • Hyun Han S; Department of Oral Microbiology and Immunology, and Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea.
  • Keun Choi S; EuBiologics Co., Ltd., Seoul, Republic of Korea. Electronic address: skchoi1027@eubiologics.com.
Vaccine ; 41(10): 1753-1759, 2023 03 03.
Article em En | MEDLINE | ID: mdl-36774331

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Febre Tifoide / Vacina Antivariólica / Vacinas Tíficas-Paratíficas Tipo de estudo: Clinical_trials Limite: Child / Humans / Infant Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Febre Tifoide / Vacina Antivariólica / Vacinas Tíficas-Paratíficas Tipo de estudo: Clinical_trials Limite: Child / Humans / Infant Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article País de publicação: Holanda